Les multiples aspects de la résistance du VIH aux antirétroviraux
- 30 September 2000
- journal article
- review article
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 30 (9) , 551-564
- https://doi.org/10.1016/s0399-077x(00)80022-0
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999
- HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyAIDS, 1999
- Outcome and Predictors of Failure of Highly Active Antiretroviral Therapy: One‐Year Follow‐Up of a Cohort of Human Immunodeficiency Virus Type 1–Infected PersonsThe Journal of Infectious Diseases, 1999
- Virological response to protease inhibitor therapy in an HIV clinic cohortAIDS, 1999
- Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitorAIDS, 1998
- Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patientsAIDS, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsAIDS, 1997
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996